Dermazone Holdings

Overview

Dermazone Holdings is an investment firm that participates in seed-stage funding for biotechnology companies.

Portfolio Companies

Website

Investments

Dermazone Holdings investments
Company	Date	Stage	Lead
Sequential	Mar 2026	Seed	Co-investor

Key People

Antwan Chahda

Managing Partner

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium

SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium

2021

2022

2023

2024

2025

2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Dermazone Holdings based?

Headquarters information for Dermazone Holdings is not publicly available.

When was Dermazone Holdings founded?

Founding year information for Dermazone Holdings is not publicly available.

How many portfolio companies does Dermazone Holdings have?

Dermazone Holdings has 1 portfolio company in Caplight's dataset.

What are some companies in Dermazone Holdings's portfolio?

Portfolio companies visible on Caplight include Sequential.

What was Dermazone Holdings's most recent investment shown here?

Dermazone Holdings's most recent investment in this portfolio sample was in Sequential in 2026.

What sectors does Dermazone Holdings focus on?

Dermazone Holdings focuses on Healthcare & Life Sciences, Enterprise Software.

What company stages does Dermazone Holdings focus on?

Dermazone Holdings typically invests at the Early stage.

Firmographic Details

Headquarters—

Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?